As a cardiologist, I frequently encounter a concerning misconception among
women: the belief that heart disease primarily affects others, while the
fear of breast cancer overshadows the significant risks posed by
cardiovascular conditions. It is essential to recognize that heart disease
is the leading cause of death for women in the United States. This stark
reality necessitates our immediate attention and action.
Many women are unaware that the symptoms of heart disease can differ from
those typically experienced by men. While chest pain is a common indicator,
women may experience more subtle signs, such as nausea, fatigue, or flu-like
symptoms. This variation can complicate diagnosis and delay treatment,
underscoring the need for increased awareness.
- Dr. Mohamad Taha, a distinguished interventional cardiologist affiliated with Prime Healthcare-Roxborough Memorial Hospital and Suburban Community Hospital, is currently accepting new patients.
- To schedule an appointment with Dr. Taha, please call (610) 290-4270.
The statistics are alarming. According to the American Heart Association,
one in three women dies from heart disease, yet many remain uninformed about
their risks. Often, women prioritize their families and careers at the
expense of their own health. It is time to shift this narrative and make
heart health a priority.
Research continues to reveal the differences in how heart disease presents
in women. For example, women are more likely to experience "atypical"
symptoms, which can lead to misdiagnosis. Additionally, conditions such as
anxiety, depression, and stress can exacerbate heart health risks in women,
further complicating the issue. It is crucial for healthcare providers to
acknowledge these differences and for women to advocate for themselves when
seeking medical attention.
Women with known risk factors—such as excess weight, high cholesterol, high
blood pressure, or a history of smoking—must prioritize their heart health.
Consulting with a healthcare provider to explore preventive measures is
vital for safeguarding heart health. This may include lifestyle
modifications such as adopting a heart-healthy diet, engaging in regular
physical activity, and managing stress effectively.
The importance of regular check-ups cannot be overstated. Routine screenings
can help identify risk factors early, allowing for timely intervention.
Women should also be aware of their family history related to heart disease,
as genetics can significantly influence one’s risk profile.
If you have concerns about your heart health or believe you may be at risk,
I encourage you to take the proactive step of scheduling an appointment with
a cardiologist.
Education is a powerful tool in the fight against heart disease. I urge
women to engage in discussions about heart health with their families,
friends, and healthcare providers. Increased awareness can lead to early
detection and improved outcomes. By recognizing the signs, understanding
risk factors, and prioritizing heart health, women can take significant
steps toward prevention.
Awareness and action are essential in combating the leading cause of death
among women. The time to act is now— your heart deserves it.
Dr. Mohamad Taha is currently accepting new patients. To schedule an
appointment, please call (610) 290-4270.
About Mohamad Taha, MD
Dr. Taha is a distinguished
interventional cardiologist affiliated with Prime Healthcare-Roxborough Memorial Hospital and Suburban Community Hospital. His expertise lies in
performing coronary and peripheral interventions, providing advanced
mechanical support, and treating various heart conditions, including
congestive heart failure and coronary artery disease.
He completed a fellowship in interventional cardiology at Lankenau Medical
Center and served as the Chief Cardiology Fellow at Danbury Hospital, which
is associated with Yale University. Dr. Taha also completed his residency in
internal medicine at UPMC Pinnacle Harrisburg, where he was recognized with
several honors for his outstanding performance. He obtained his medical
degree from St. George's University and holds Bachelor of Science degrees in
Molecular and Microbiology from the University of Central Florida, as well
as Biology from the American University of Beirut.
Before embarking on his residency, Dr. Taha was involved in research focused
on antiplatelet therapy at the University of Florida, contributing to
numerous peer-reviewed publications. He is board certified in Internal
Medicine and Cardiovascular Disease, with additional certifications in
Interventional Cardiology, underscoring his commitment to excellence in
cardiology and patient care.
